Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects.

Hsu CY, Rizaev J, AlAbdulhadi SAS, Abbas Al-Khafaji ZK, Gupta PK, Samikan KR, Sahoo S, Bainsal N

Open source

DOI
10.1016/j.jpet.2026.104903
Published
2026 Jun
Container
The Journal of pharmacology and experimental therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jpet.2026.104903,
  title = {Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects.},
  author = {Hsu CY and Rizaev J and AlAbdulhadi SAS and Abbas Al-Khafaji ZK and Gupta PK and Samikan KR and Sahoo S and Bainsal N},
  year = {2026},
  journal = {The Journal of pharmacology and experimental therapeutics},
  doi = {10.1016/j.jpet.2026.104903},
  url = {https://doi.org/10.1016/j.jpet.2026.104903}
}

RIS

TY  - JOUR
TI  - Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects.
AU  - Hsu CY
AU  - Rizaev J
AU  - AlAbdulhadi SAS
AU  - Abbas Al-Khafaji ZK
AU  - Gupta PK
AU  - Samikan KR
AU  - Sahoo S
AU  - Bainsal N
PY  - 2026
JO  - The Journal of pharmacology and experimental therapeutics
DO  - 10.1016/j.jpet.2026.104903
UR  - https://doi.org/10.1016/j.jpet.2026.104903
ER  - 

APA

CY, H., J, R., SAS, A., ZK, A. A., PK, G., KR, S., S, S., & N, B. (2026). Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects.. The Journal of pharmacology and experimental therapeutics. https://doi.org/10.1016/j.jpet.2026.104903

Source records